A Resurgence in Plasma: Trends in The Industry
Global demand for plasma-derived therapies (PDTs) continues to swell—the compacting result of an aging population, clinical successes, and recent applications for both widespread diseases and multiple rare conditions. Serving these needs has been a significant challenge over the last two and a half years, with a decline in plasma donations due to the COVID-19 pandemic. The donation shortage added strain to an already complex supply chain of plasma-derived products and made meeting the rising patient demand more difficult than ever before. Fortunately, in recent months, several major players in the industry have announced a rebound in plasma donations to pre-pandemic levels. This encouraging news could provide a resurgence to the plasma industry with accelerated growth in the coming years.